ATM and breast cancer: A recent meta-analysis estimated that truncating ATM variants were associated with a relative risk of 2.8,4 and several studies have reported that certain subgroups of missense variants also contribute to BC risk.5–9 CHEK2 encodes a checkpoint kinase that interacts with cell cycle regulators and DNA repair proteins.